National and Kapodistrian University of Athens
Αιτιολογία της αναιμίας στην τελικού σταδίου χρόνια καρδιακή ανεπάρκεια
Abstract
dc:descriptionIntroduction: The prevalence of chronic heart failure in the general population is increasing. End-stage chronic heart failure portends a poor prognosis. Anemia is commonly encountered in patients with chronic heart failure, with increasing prevalence as the severity of heart failure increases. Anemia can have an adverse impact on the cardiovascular system, and has been found to be independently associated with poorer quality of life, and greater morbidity and mortality in chronic heart failure patients. The main pathophysiological mechanisms that are thought to contribute to the development of anemia in chronic heart failure include underlying chronic systemic inflammation, which is associated with inhibition of erythropoiesis, impaired absorption and utilization of iron, absolute iron deficiency, chronic renal dysfunction, blunted erythropoietin production and bone marrow response to erythropoietin, as well as drug-induced anemia due to inhibitors of the renin-angiotensin system. The role of iron deficiency has not been clarified given that the iron indices are influenced by co-existing inflammation.Objective: We hypothesized that iron deficiency is common in end-stage chronic heart failure patients. The aim of the study was to investigate all the main possible etiologic mechanisms of clinically-significant anemia in patients with end-stage heart failure.Methods: We performed a single-center, cross-sectional study to determine the prevalence of the different etiologies for clinically-significant anemia, in consecutive adult patients with chronic heart failure due to systolic dysfunction, who had not responded to optimized heart failure medical treatment and required intravenous infusion of inotropic drugs. We defined clinically-significant anemia as a hemoglobin concentration lower or equal to 11.5 and 12 g/dl, for females and males, respectively, after clinical stabilization. We excluded patients with anemia attributed to a concomitant disorder, those with serum creatinine higher than 3 mg/dl, and those who had recently received iron intravenously or epoetin. The medical history was taken from the included patients and physical examination was performed, as well as a standard cardiology work-up. Blood was drawn for a full laboratory panel with specific tests for anemia, including reticulocytes, ferritin, erythropoietin, vitamin B12, folic acid, thyroid stimulating hormone, and inflammatory markers. A fecal occult blood test was ordered. Bone marrow was aspirated for evaluation of the iron stores and the red cell volume was measured with 51Cr-labeled red cells. The patients were followed prospectively for major clinical events, for 3 months.Results: We included 37 patients (35 males), with mean age of 57.9±10.9 years and median heart failure duration of 60 months. Twenty-six (70.3%) patients were in NYHA functional class IV, and the remaining were in class III. The mean pulmonary capillary wedge pressure was 25.8±7.5 mmHg, the cardiac index was 1.9±0.5 L/m2/min, and the left ventricular ejection fraction was 22.5±5.9%. The patients had a mean hemoglobin concentration of 10.1±0.9 g/dl, ferritin of 113.2±94.4 ng/ml, erythropoietin of 68.6±54.7 mU/ml, C-reactive protein of 3.4±3.8 mg/dl, and serum creatinine of 1.7±0.6 mg/dl. Twenty-seven (73.0%, 95% confidence interval 57.1-85.4%) out of the 37 patients had iron deficiency (absence of bone marrow iron stores). According to the adjusted for body weight criteria for red cell volume, all 15 patients with iron deficiency had true anemia,while out of the remaining patients, 7 (18.9%) had anemia of chronic disease, 2 (5.4%) had hemodilution (normal red cell volume and increased plasma volume), and 1 (2.7%) had drug-induced anemia due to angiotensin converting enzyme inhibitors. Serum ferritin had a good diagnostic value for iron-deficiency versus non-iron deficiency (75.3±59.1 versus 211.9±99.9 ng/ml, p=0.002; area under curve 0.890, 95% confidence interval: 0.783-0.997). According to the international criteria for prediction of the normal red cell and plasma volumes by the body surface area, 8 (33.3%) out of the 24 specifically-examined patients had true anemia, 7 (29.2%) had pseudoanemia with normal plasma volumes and 9 (37.5%) had hemodilution, with no relevant differences between iron-deficient and non-iron-deficient patients. Regarding all 37 patients, 2 additionally had hypothyroidism, 6 had estimated glomerular filtration rate below 30 ml/min/1.73m2, while 3 had a low ratio of log observed to predicted erythropoietin. Within 3 months, 20 (54.1%) of the patients survived without need for urgent cardiac surgery. There was no association between iron deficiency and hemodilution with survival. Conclusion: Iron deficiency is very common in end-stage chronic heart failure patients with anemia. Serum ferritin could serve as a non-invasive diagnostic marker of iron deficiency in chronic heart failure, but the degree of underlying inflammation should be taken into consideration. Irrespectively of the iron status of patients, there is considerable variation in the red cell and plasma volumes. The comprehensive diagnostic algorithm of anemia followed in our study, allows for the individualization of treatment in patients with end-stage chronic heart failure, whose prognosis is dismal.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Καραγεωργόπουλος, Δρόσος
- Karageorgopoulos, Drosos
Subjects
dc:subject × 20- Αναιμία
- Καρδιακή ανεπάρκεια
- Σιδηροπενία
- Αναιμία χρόνιας νόσου
- Αιμοαραίωση
- Ερυθροποιητίνη
- Φερριτίνη
- Νεφρική δυσλειτουργία
- Anemia
- Heart failure
- Iron deficiency
- Anemia of chronic disease
- Hemodilution
- Erythropoietin
- Ferritin
- Renal dysfunction
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42482